Congress: Now is the time to Stop Diabetes
Over 30 million Americans live with diabetes; 84 million more have prediabetes and the epidemic keeps growing. Unless we take action now, one in three Americans will be diagnosed with the disease by 2050. And with every diagnosis, another American faces terrible complications, including kidney failure, blindness, amputation and even death.
Increase Federal Funding for Diabetes Research and Programs
- Allocate $2.165 billion for the National Institutes of Health's (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the primary federal agency that conducts research to find a cure and advance treatments for diabetes. This investment in NIDDK is needed to advance the nation's efforts to develop new and superior treatments, enhance disease detection and management, improve the prevention of diabetes and its complications, and ultimately discover a cure. Read more in our NIDDK fact sheet.
- Provide $185 million for the Centers for Disease Control and Prevention's (CDC) Division of Diabetes Translation (DDT) whose mission is to eliminate the preventable burden of diabetes through research, education, and by translating science into clinical practice. This investment in the DDT will allow CDC to build upon its innovative diabetes translational research, strengthen surveillance efforts and expand national, state and community programs. These programs provide essential information and education about diabetes risk, complications, treatment and management to the public, health care providers and patients. See our CDC fact sheet.
- Support $30 million for the National Diabetes Prevention Program. The National Diabetes Prevention Program can dramatically reduce the number of new diabetes cases in individuals with prediabetes. Funding for and continued implementation of the National Diabetes Prevention Program would allow the CDC to dramatically expand the reach of proven, evidence-based community programs to identify, refer, and provide those at high-risk for diabetes with cost-effective interventions.
- Support 5-year, $200 million per program per year reauthorization of the Special Diabetes Program, which expires September 30, 2019 and has tremendous bipartisan support. For over twenty years, a key component of the federal government’s efforts to prevent, treat, and cure diabetes has been the Special Diabetes Program for Indians (SDPI) at the Indian Health Service (IHS) and the Special Statutory Funding Program for Type 1 Diabetes Research (SDP-type 1) at the National Institutes of Health (NIH). Together, they make up the Special Diabetes Program (SDP). Both components of SDP provide a clear return on investment. Learn more about SDP.
Make Insulin Affordable
- The average price of insulin has skyrocketed in recent years-nearly tripling between 2002 and 2013.
- More than 480,000 individuals have signed the ADA's petition calling for greater transparency across the insulin supply chain, and for Congress to hold hearings to identify the reasons for the dramatic increases in insulin prices and take action to ensure all people who need insulin have affordable access to this life sustaining medication.
- The ADA recommends a number of actions to help bring down the cost of insulin for those who need it, including:
- increasing pricing transparency throughout the insulin supply chain;
- lowering or removing patient cost-sharing for insulin; and
- increasing access to health care coverage for all people with diabetes.
- Insulin Affordability Fact Sheet